Aignostics logo
Startup

Aignostics

See Aignostics's full profile

BOOK A DEMO
Headquarters

Germany

Founded Year

2020

Total Funding

$6.9M

Employees

11 - 50

Status

Active


About Aignostics

Today, manual microscopic evaluation of tissue samples by pathologists is the gold standard for diagnosing cancer as well as many degenerative, infectious and inflammatory diseases.

Headquarters

Schumannstraße 17, 10117 Berlin, Germany


General Information on Aignostics

Brand name Aignostics
Company name Aignostics GmbH
Register number HRB 215748
Website https://aignostics.com/
Founded year 2020
Employees 11 - 50
Founding team

Maximilian Alber

Viktor Matyas

Contact [email protected]
+491709305517

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Aignostics

Scrip News 21.09.2022
Minute Insight: Aignostics Completes Raise To Fund AI Pathology Platform

Berlin-based Aignostics, developers of digital pathology solutions, has completed an oversubscribed €14m ($14m) series A financing round. The round was led by Wellington Partners – who were involved in Quanta Dialysis’ $245m series D round – and was joined by Boehringer Ingelheim Venture Fund (BIVF), VC Fonds Technologie managed by IBB Ventures, High-Tech Gründerfonds (HTGF) and the CARMA Fund. (Also see "Quanta Raises $245M In Series D, Plans ...

Aignostics news
analytica-world.com (Germany) 19.09.2022
Aignostics Raises €14m Series A to Advance AI-powered Pathology

Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14m Series A financing round. Wellington Partners led the round, joined by existing investors Boehringer Ingelheim Venture Fund (BIVF), VC Fonds Technologie managed by IBB Ventures and High-Tech Gründerfonds (HTGF). CARMA ...

Aignostics news
Analytica-World 19.09.2022
Aignostics erhält 14 Millionen Euro für Weiterentwicklung KI-gestützter Pathologie

Aignostics, ein Spin-off der Charité – Universitätsmedizin Berlin, das neuartige digitale Pathologielösungen mit “Explainable AI” für die pharmazeutische Forschung und Diagnostik entwickelt, gab den Abschluss einer überzeichneten „Series A“-Finanzierungsrunde in Höhe von 14 Millionen Euro bekannt. Wellington Partners führte die Runde als Neuinvestor an. Die bestehenden Investoren Boehringer Ingelheim Venture Fund (BIVF), der von IBB Ventures ...

Aignostics news
Deutsche Startups 16.09.2022
+++ Morpheus Space +++ Candis +++ Cure +++ Aignostics +++ riskmethods +++ Berlin Organics +++ Surf4Shoes +++ Pitch +++ Infarm +++

+++ #StartupTicker-Wochenrückblick +++ codary +++ Morpheus Space +++ Candis +++ Cure +++ Aignostics +++ riskmethods +++ Vcoach +++ HRworks +++ Frischepost +++ Berlin Organics +++ Surf4Shoes +++ Pitch +++ Infarm +++ Was gibt’s Neues? In unserem #StartupTicker-Wochenrückblick liefern wir einen schnellen Überblick darüber, was in der deutschsprachigen Startup-Szene zuletzt wirklich wichtig war! #StartupTicker – Was zuletzt wirklich wichtig war! ...

Aignostics news
Labpulse.com 16.09.2022
Aignostics nabs 14M euros in Series A financing

-- Berlin-based digital pathology software company Aignostics has nabbed 14 million euros ($13.9 million) in a Series A financing round. September 16, 2022 The company, a 2018 spinoff from the Digital Health Accelerator program at the Berlin Institute of Health, said that it is developing novel digital pathology solutions with its Explainable AI technology for pharmaceutical research and diagnostics. Explainable AI reverse-engineers ...

PitchBook (Online) 16.09.2022
Pathology platform Aignostics picks up €14M | PitchBook

Wellington Partners has led a €14 million Series A for Berlin-based Aignostics. The startup's AI-based image analysis system is designed to assist pathologists in interpreting tissue samples.

Aignostics news
Deutsche Startups 15.09.2022
Morpheus Space sammelt 28 Millionen ein – Cure streicht 15 Millionen ein – Aignostics bekommt 14 Millionen

Der #DealMonitor, unsere Übersicht über Investments und Exits, bietet werktäglich alle Deals des Tages. Heute geht es um Morpheus Space, Cure, Aignostics, Kipu Quantum, Peers, Wanko, kiwiHR, Medbee und Print Royal. Im #DealMonitor für den 15. September werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen ...

Aignostics news
Deal Advisors by Majunke (Germany) (German) 15.09.2022
Aignostics erhält 14 Millionen Euro „Series A“-Finanzierung für Weiterentwicklung KI-gestützter Pathologie

Aignostics, ein Spin-off der Charité – Universitätsmedizin Berlin, das neuartige digitale Pathologielösungen mit “Explainable AI” für die pharmazeutische Forschung und Diagnostik entwickelt, gab heute den Abschluss einer überzeichneten „Series A“-Finanzierungsrunde in Höhe von 14 Millionen Euro bekannt. Wellington Partners führte die Runde als Neuinvestor an. Die bestehenden Investoren Boehringer Ingelheim Venture Fund (BIVF), der von IBB ...

Aignostics news
Tech.eu 15.09.2022
Berlin-based Aignostics scoops €14 million to decode diagnostics with AI-driven pathology platform

The startup offers AI models to cover key tissue staining technologies, which enable the acceleration of pre-clinical and translational research to improve understanding of disease biology, mode of action, or novel biomarkers and drug response characteristics While pathologists are outstanding at interpreting individual tissue samples qualitatively, deep analysis of large data sets is a challenge better suited for AI. Attempting to address this, ...

FOX 40 WICZ TV (NY) 15.09.2022
Aignostics Raises €14m Series A to Advance AI-powered Pathology

Oversubscribed financing round with top-tier life science investors, led by Wellington Partners

Aignostics news